Pain and fever medications later in pregnancy could lead to complications, FDA says

News

Pixabay

(WWTI) — The Food and Drug Administration is warning pregnant women to avoid certain pain and fever medications. The FDA now requires labeling changes for the nonsteroidal anti-inflammatory drug to include warning labels for pregnant women.

According to the FDA, certain medications taken by women at 20 weeks or later in pregnancy, have been linked to serious kidney problems in unborn babies. These issues have led to low levels of amniotic fluid and can cause pregnancy-related complications.

“It is important that women understand the benefits and risks of the medications they may take over the course of their pregnancy,” said Acting Director of FDA’s Center for Drug Evaluation and Research Patrizia Cavazzoni, M.D. “To this end, the agency is using its regulatory authority to inform women and their health care providers about the risks of NSAIDs are used after around 20 weeks of pregnancy and beyond.”

Medications included in the October 15 release include a nonsteroidal anti-inflammatory drug such as ibuprofen, naproxen, diclofenac, and celecoxib. However, the FDA stated that these recommendations do not apply to the use of low-dose aspirin: 81 mg.

LATEST STORIES

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Click Below to set up your cable box

Download our news app

App Store Link
Google Play Link
Early Voting Locations

Coronavirus Outbreak

More Coronavirus Outbreak

Classroom Progress Report

More Classroom Progress Report